Erratum: SCF increases cardiac stem cell migration through PI3K/AKT and MMP‑2/‑9 signaling (Int J Mol Med 34 (112‑118) (2014) DOI: 10.3892/ijmm.2014.1773);SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 112-118

  Guo, Junli ^a   Jie, Wei ^b   Shen, Zhihua ^b   Li, Mengsen ^a   Lan, Youling ^a   Kong, Yueqiong ^a   Guo, Shaoli ^a   Li, Tianfa ^a   Zheng, Shaojiang ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac stem cells; Cell migration; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Pi3k akt signaling; Stem cell factor (scf) c kit system

Indexed keywords

GELATINASE A; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEM CELL FACTOR; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MIGRATION; ENZYME ACTIVITY; HEART; HEART INFARCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MALE; METABOLISM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MORPHOLINES; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEM CELL FACTOR; STEM CELLS;

EID: 84902687293     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2022.5091     Document Type: Erratum

References (40)

1. World Health Organization: The top 10 causes of death. http://who.int/ mediacentre/factsheets/fs310/en/. Accessed July, 2013.
2. Koudstaal S, Jansen Of Lorkeers SJ, et al: Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med 2: 434-443, 2013.
3. Hou J, Wang L, Jiang J, et al: Cardiac stem cells and their roles in myocardial infarction. Stem Cell Rev 9: 326-338, 2013.
4. Karantalis V, Balkan W, Schulman IH, Hatzistergos KE and Hare JM: Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol 303: H256-H270, 2012.
5. Bolli R, Tang XL, Sanganalmath SK, et al: Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128: 122-131, 2013.
6. Ptaszek LM, Mansour M, Ruskin JN and Chien KR: Towards regenerative therapy for cardiac disease. Lancet 379: 933-942, 2012.
7. Bolli R, Chugh AR, D'Amario D, et al: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378: 1847-1857, 2011.
8. Makkar RR, Smith RR, Cheng K, et al: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379: 895-904, 2012.
9. Beltrami AP, Barlucchi L, Torella D, et al: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003. (Pubitemid 37186770)
10. Oh H, Bradfute SB, Gallardo TD, et al: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318, 2003. (Pubitemid 37271557)
11. Laugwitz KL, Moretti A, Lam J, et al: Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653, 2005. (Pubitemid 40282999)
12. Winter EM, Grauss RW, Hogers B, et al: Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation 116: 917-927, 2007. (Pubitemid 47300916)
13. Guo J, Jie W, Kuang D, et al: Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway. Int J Exp Pathol 90: 355-364, 2009.
14. Williams AR, Hatzistergos KE, Addicott B, et al: Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127: 213-223, 2013.
15. Ellison GM, Vicinanza C, Smith AJ, et al: Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154: 827-842, 2013.
16. Cui G, Shan L, Hung M, et al: A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways. Int J Cardiol 168: 1349-1359, 2013.
17. Tekin D, Dursun AD and Xi L: Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin 31: 1085-1094, 2010.
18. Gude NA, Emmanuel G, Wu W, et al: Activation of Notch-mediated protective signaling in the myocardium. Circ Res 102: 1025-1035, 2008. (Pubitemid 351667856)
19. Saxena A, Fish JE, White MD, et al: Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117: 2224-2231, 2008.
20. Wang X, Chen Y, Kuang D, et al: The cardioprotective effects of erythropoietin in myocardial ischemic injury via upregulation of SDF-1 by JAK2/STAT3. Int J Cardiol 156: 320-322, 2012.
21. Kuang D, Zhao X, Xiao G, et al: Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol 103: 265-273, 2008.
22. Tang J, Wang J, Kong X, et al: Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res 315: 3521-3531, 2009.
23. Lovell MJ, Yasin M, Lee KL, et al: Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway. Atherosclerosis 213: 67-76, 2010.
24. Lu G, Haider HK, Jiang S and Ashraf M: Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 119: 2587-2596, 2009.
25. Zhang Z, Li S, Cui M, et al: Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Res Cardiol 108: 333, 2013.
26. Choi SH, Jung SY, Suh W, Baek SH and Kwon SM: Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy. Transplant Proc 45: 420-426, 2013.
27. He JQ, Vu DM, Hunt G, Chugh A, Bhatnagar A and Bolli R: Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One 6: e27719, 2011.
28. + cardiac stem cells derived from adult rat hearts. Stem Cells Dev 19: 105-116, 2010.
29. Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, et al: Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res 107: 429-441, 2010.
30. Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y and Sugiyama H: The C-kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci 9: 435-443, 2013.
31. Lutz M, Rosenberg M, Kiessling F, et al: Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit+ bone marrow-derived stem cells. Cardiovasc Res 77: 143-150, 2008. (Pubitemid 351195155)
32. She T, Wang X, Gan Y, et al: Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities. Int J Mol Med 30: 1313-1320, 2012.
33. Wan J, Deng Y, Guo J, et al: Hyperhomocysteinemia inhibited cardiac stem cell homing into the peri-infarcted area post myocardial infarction in rats. Exp Mol Pathol 91: 411-418, 2011.
34. Petrie RJ, Doyle AD and Yamada KM: Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10: 538-549, 2009.
35. Van Haastert PJ and Devreotes PN: Chemotaxis: signalling the way forward. Nat Rev Mol Cell Biol 5: 626-634, 2004. (Pubitemid 39025063)
36. Berrier AL and Yamada KM: Cell-matrix adhesion. J Cell Physiol 213: 565-573, 2007. (Pubitemid 350058247)
37. Libra M, Scalisi A, Vella N, et al: Uterine cervical carcinoma: role of matrix metalloproteinases (Review). Int J Oncol 34: 897-903, 2009.
38. Neth P, Ries C, Karow M, Egea V, Ilmer M and Jochum M: The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Rev 3: 18-29, 2007. (Pubitemid 47484973)
39. Wang L, Zhang ZG, Zhang RL, et al: Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 26: 5996-6003, 2006. (Pubitemid 44318365)
40. Urbanek K, Rota M, Cascapera S, et al: Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673, 2005. (Pubitemid 41416335)